logo
New Zealand Prime Minister Luxon talks trade in meeting with China's Xi

New Zealand Prime Minister Luxon talks trade in meeting with China's Xi

Yahoo7 hours ago

BEIJING (AP) — The prime minister of New Zealand stressed the importance of his country's trade ties with China in a meeting with Chinese leader Xi Jinping on Friday.
Christopher Luxon, on his first visit to China since becoming prime minister in late 2023, flew to Beijing after two days of meetings with officials and business leaders in Shanghai, China's commercial center.
He wants to maintain healthy trade relations with China, an important market for New Zealand products, despite differences over regional and global security issues and China's growing divide with the United States.
'Our trade and economic links are complementary and contribute to prosperity in both countries,' he was quoted as saying in a news release following his meeting with Xi.
Luxon said he raised the necessity of reducing tensions in the Indo-Pacific region and the importance of what he called 'the key role' that China can play in helping to resolve global challenges such as the war in Ukraine.
'In a complex world, open dialogue is more important than ever,' Luxon said in a post about the meeting on X.
His exchange with Xi came one day after revelations that New Zealand had suspended millions of dollars in aid to the Cook Islands over concerns about the latter's deepening ties with China.
China accounts for more than 20% of New Zealand's exports of goods and services.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

President Trump says he'll set unilateral tariff rates within weeks
President Trump says he'll set unilateral tariff rates within weeks

Yahoo

time14 minutes ago

  • Yahoo

President Trump says he'll set unilateral tariff rates within weeks

US President Donald Trump told reporters on Wednesday that he would send letters to trading partners in the next week or two, outlining unilateral tariff rates. 'We're going to be sending letters out in about a week and a half, two weeks, to countries, telling them what the deal is,' Trump said at the John F. Kennedy Center for the Performing Arts in Washington. 'At a certain point, we're just going to send letters out. And I think you understand that, saying this is the deal, you can take it or leave it,' he added. This would put Trump ahead of his tariff deadline, as the president previously paused so-called 'reciprocal' duties for 90 days until 8 July. The higher rates are set to kick in on the 9th. Trump told reporters at the Kennedy Center that a delay to the deadline is unlikely, although US Treasury Secretary Scott Bessent previously suggested there may be some flexibility. "It is highly likely that those countries - or trading blocs as is the case with the EU - who are negotiating in good faith, we will roll the date forward to continue the good-faith negotiations," Bessent told the House Ways and Means Committee. "If someone is not negotiating, then we will not." Related EU targets Trump's 'Big Beautiful Bill' over tax provision in tariff talks US federal appeals court rules Trump tariffs may remain in effect while appeals process continues The US has thus far only managed to secure a trade framework with the UK, as well as clinching a tariff deal with China. Trump was nonetheless upbeat about negotiations on Wednesday. "We're rocking in terms of deals," he said. "We're dealing with quite a few countries and they all want to make a deal with us." Following talks in London, Trump said on Wednesday that magnets and rare earths would be supplied up front by China and that the US would allow Chinese students into its colleges and universities. The president added that a 55% tariff would be applied to Chinese imports. A White House official, who was not authorised to discuss the terms publicly, said the 55% was not an increase on the previous 30% tariff on China because Trump was including other pre-existing import taxes. Specifically, the president was tallying up his 10% baseline tariff, the 20% fentanyl trafficking levy and a 25% pre-existing tariff on China. In May, the US agreed upon a trade framework with the UK, which allows US goods to be fast-tracked through customs and reduces trade barriers on a number of products. The framework lowers US duties on British steel, aluminum and cars, although there are some knots to work out, meaning the specifics of the deal could arrive later than the 9 July deadline. US Commerce Secretary Howard Lutnick said on Wednesday that a deal with the European Union will likely be among the final trade agreements concluded by the United States. 'I'm optimistic that we can get there with Europe. But Europe will be probably [at] the very, very end,' Lutnick told CNBC. In May, Trump threatened a 50% tariff on EU goods coming to the US, although he later said he would hold off on this threat until 9 July. The president originally placed a 20% so-called 'reciprocal' levy on EU goods, but this duty was lifted during the 90-day pause window. Sign in to access your portfolio

Nvidia (NVDA) Rises After Cathie Wood Rebuilds $18.5M Stake Near All-Time High
Nvidia (NVDA) Rises After Cathie Wood Rebuilds $18.5M Stake Near All-Time High

Yahoo

time28 minutes ago

  • Yahoo

Nvidia (NVDA) Rises After Cathie Wood Rebuilds $18.5M Stake Near All-Time High

Cathie Wood's Ark Innovation ETF (ARKK, Financials) resumed its position in Nvidia (NVDA, Financials), purchasing 128,163 shares valued at approximately $18.5 million on June 16, as the stock trades just 2.7% below its all-time high of $149.41. The move marks a reversal from 2022, when Wood exited her Nvidia position amid tightening U.S. export controls and macroeconomic concerns. She began rebuilding the stake in April following eased trade tensions and the Trump administration's decision to roll back AI-related export restrictions. Warning! GuruFocus has detected 4 Warning Signs with NVDA. The buy came shortly after Nvidia reported fiscal first-quarter results on May 28, with adjusted earnings of 96 cents per share on $44.06 billion in revenue, beating expectations of 93 cents and $43.31 billion, respectively. For the July quarter, the company forecast $45 billion in revenue, nearly $1 billion below consensus estimates, citing the impact of chip restrictions to China. Nvidia said revenue would have been about $8 billion higher without those curbs. China accounted for 13% of the company's revenue in the past fiscal year. Despite geopolitical risks, Nvidia stock is up 8.3% year to date. Wood's purchase comes as Ark Innovation ETF gains momentum, rising 15.9% in 2025 through June 18, outpacing the S&P 500's 1.9% increase. Wood's strategy remains focused on innovation platforms such as artificial intelligence, robotics, and blockchain, with Nvidia seen as a core holding aligned with those themes. Her flagship fund, however, has faced volatility, including a 60% decline in 2022 and a five-year annualized return of negative 0.3%, compared with the S&P 500's 15.7%. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com
Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com

Yahoo

time43 minutes ago

  • Yahoo

Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com

Aurora Cannabis (ACB) announced that it has become aware of 'a second instance of misinformation' posted on news website On June 18, Aurora advised the market that an article posted on incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, a second article was posted on that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for distribution of medical cannabis in Germany and other EU markets. 'The company categorically denies both articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm GmbH with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions. The erroneous articles posted on state that they were generated 'with the support of AI' and reviewed by an editor. The company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that should not be considered a credible source of information regarding the company. Any information regarding material corporate transactions will be announced directly by the company to the market as soon as it is appropriate to do so,' Aurora stated. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ACB: Disclaimer & DisclosureReport an Issue Aurora Cannabis Reports Record Revenue and Growth Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics Aurora Cannabis denies acquisition of MedLeaf Therapeutics Morning Movers: Circle rises following regulatory framework for stablecoins Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store